Homestead Advisers’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $25.3M | Sell |
210,577
-2,100
| -1% | -$242K | 0.68% | 47 |
|
|
2025
Q4 | $22.4M | Sell |
212,677
-26,427
| -11% | -$2.48M | 0.59% | 48 |
|
|
2025
Q3 | $20.1M | Sell |
239,104
-399,300
| -63% | -$32.9M | 0.48% | 50 |
|
|
2025
Q2 | $50.5M | Sell |
638,404
-40,400
| -6% | -$3.21M | 1.2% | 40 |
|
|
2025
Q1 | $60.9M | Hold |
678,804
| – | – | 1.49% | 33 |
|
|
2024
Q4 | $67.5M | Buy |
678,804
+24,800
| +4% | +$2.56M | 1.63% | 31 |
|
|
2024
Q3 | $74.3M | Sell |
654,004
-500
| -0.1% | -$59.4K | 1.77% | 25 |
|
|
2024
Q2 | $81M | Sell |
654,504
-11,200
| -2% | -$1.44M | 2% | 20 |
|
|
2024
Q1 | $87.8M | Sell |
665,704
-1,000
| -0.1% | -$123K | 2.06% | 23 |
|
|
2023
Q4 | $72.7M | Buy |
666,704
+1,100
| +0.2% | +$114K | 1.86% | 26 |
|
|
2023
Q3 | $68.5M | Buy |
665,604
+10,000
| +2% | +$1.08M | 1.9% | 26 |
|
|
2023
Q2 | $75.7M | Buy |
655,604
+3,200
| +0.5% | +$363K | 2.01% | 22 |
|
|
2023
Q1 | $69.4M | Sell |
652,404
-13,700
| -2% | -$1.48M | 1.93% | 25 |
|
|
2022
Q4 | $73.9M | Sell |
666,104
-2,500
| -0.4% | -$256K | 1.97% | 23 |
|
|
2022
Q3 | $57.6M | Sell |
668,604
-1,500
| -0.2% | -$134K | 1.74% | 28 |
|
|
2022
Q2 | $61.1M | Hold |
670,104
| – | – | 1.73% | 27 |
|
|
2022
Q1 | $55M | Sell |
670,104
-10,200
| -1% | -$804K | 1.35% | 33 |
|
|
2021
Q4 | $52.1M | Sell |
680,304
-4,900
| -0.7% | -$390K | 1.2% | 37 |
|
|
2021
Q3 | $51.5M | Buy |
685,204
+2,700
| +0.4% | +$205K | 1.25% | 36 |
|
|
2021
Q2 | $53.1M | Sell |
682,504
-111,675
| -14% | -$8.31M | 1.23% | 36 |
|
|
2021
Q1 | $58.4M | Sell |
794,179
-191,155
| -19% | -$14.1M | 1.4% | 32 |
|
|
2020
Q4 | $76.9M | Sell |
985,334
-23,370
| -2% | -$1.79M | 1.9% | 19 |
|
|
2020
Q3 | $79.8M | Sell |
1,008,704
-349,089
| -26% | -$27.3M | 2.19% | 12 |
|
|
2020
Q2 | $100M | Buy |
1,357,793
+734
| +0.1% | +$55.3K | 2.57% | 11 |
|
|
2020
Q1 | $99.6M | Sell |
1,357,059
-50,556
| -4% | -$3.97M | 2.94% | 10 |
|
|
2019
Q4 | $122M | Sell |
1,407,615
-14,356
| -1% | -$1.18M | 2.54% | 12 |
|
|
2019
Q3 | $114M | Sell |
1,421,971
-49,653
| -3% | -$3.98M | 2.3% | 12 |
|
|
2019
Q2 | $118M | Sell |
1,471,624
-416,348
| -22% | -$31.9M | 2.23% | 16 |
|
|
2019
Q1 | $150M | Sell |
1,887,972
-73,360
| -4% | -$5.49M | 2.8% | 13 |
|
|
2018
Q4 | $143M | Hold |
1,961,332
| – | – | 2.78% | 11 |
|
|
2018
Q3 | $133M | Hold |
1,961,332
| – | – | 2.03% | 19 |
|
|
2018
Q2 | $114M | Hold |
1,961,332
| – | – | 1.78% | 21 |
|
|
2018
Q1 | $102M | Hold |
1,961,332
| – | – | 1.53% | 23 |
|
|
2017
Q4 | $105M | Hold |
1,961,332
| – | – | 1.51% | 23 |
|
|
2017
Q3 | $120M | Hold |
1,961,332
| – | – | 1.82% | 20 |
|
|
2017
Q2 | $120M | Hold |
1,961,332
| – | – | 1.88% | 21 |
|
|
2017
Q1 | $119M | Hold |
1,961,332
| – | – | 1.9% | 20 |
|
|
2016
Q4 | $110M | Buy |
1,961,332
+500,441
| +34% | +$29.3M | 1.73% | 20 |
|
|
2016
Q3 | $87M | Buy |
1,460,891
+529,240
| +57% | +$30.9M | 1.44% | 25 |
|
|
2016
Q2 | $51.2M | Hold |
931,651
| – | – | 0.88% | 43 |
|
|
2016
Q1 | $47M | Buy |
+931,651
| New | +$45.6M | 0.84% | 41 |
|
Other funds holding MRK
VCM
VPM
Homestead Advisers's MRK Position: Q1 2026 in Review
Homestead Advisers reduced its Merck (MRK) stake by 0.99% in Q1 2026, selling an estimated $242K and leaving 210,577 shares worth $25.3M. The position accounts for 0.68% of the portfolio, ranked #47.
Homestead Advisers first reported a position in MRK in Q1 2016 and has held it in 41 quarters since. The position peaked at $150M in Q1 2019. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Homestead Advisers held 210,577 shares of Merck worth $25.3M as of Q1 2026.
- Homestead Advisers sold 2,100 Merck shares in Q1 2026, an estimated $242K.
- Merck made up 0.68% of Homestead Advisers's portfolio in Q1 2026, its #47 holding.
- Homestead Advisers first reported a position in Merck in Q1 2016 and has held it in 41 quarters since.
- Homestead Advisers's Merck position peaked at $150M in Q1 2019.
- 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Homestead Advisers's 13F filing for Q1 2026, filed 8 May 2026.